Press Release
Lantheus Highlights Preliminary Study Results Demonstrating Potential of NM-01, a Novel Technetium-99m SPECT/CT Imaging Agent, to Assess PD-L1 Expression for Immunotherapy in Cancer
June 13, 2022
Read More at Our Investor Site
Because we’re making headlines
We do it by making a difference in the lives of our patients. Stay current with the latest news, information and events at Lantheus. Please visit our investor site for a complete list of recent and archived press releases. Follow us on LinkedIn for social media updates.
For media resources, including images, logos, videos, and more, browse our media library.
Latest Press Releases
Press Release
Lantheus’ PYLARIFY AI™ Platform Demonstrates Higher Efficiency and Consistency While Maintaining Accuracy for Assessment of PSMA Imaging in Prostate Cancer
June 13, 2022
Read More at Our Investor SitePress Release
Lantheus to Present at the Jefferies Healthcare Conference
June 2, 2022
Read More at Our Investor Site
